The evolution of adjunctive antiplatelet therapy in non urgent PCI
An EBAC Accredited Educational Programme supported with an unrestricted educational grant from AstraZeneca.
- Chairpersons: Hugo KATUS, Patrick W. SERRUYS
- Speakers: Patrick W. SERRUYS, Andreas BAUMBACH, Ph. Gabriel STEG, Marco VALGIMIGLI, Hugo KATUS
To learn about evolving evidence in adjunctive antiplatelet therapy
To appreciate the importance of discharge treatment plans
To understand the issues surrounding short versus long-term antiplatelet therapy
This programme was EBAC accredited during the EuroPCR Congress 2014, however no CME credits will be provided for viewing this web-cast.
Prof. Katus is Clinical Director of the Department of Cardiology, Angiology and Pneumology, as well as Managing Director of the Medical Clinic, Heidelberg.
Patrick W. Serruys
Patrick W. Serruys, is Professor of Interventional Cardiology at the Interuniversity Cardiological Institute of The Netherlands, and the Erasmus University.